Viscient Biosciences Company
Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics (genomics, transcriptomics, metabolomics) analysis to develop drugs across a range of therapeutic areas, with an initial focus in non-alcoholic steatohepatitis (NASH,“fatty liver disease”).
Founded and staffed by a team composed of former Organovo and Ardea Biosciences scientists and entrepreneurs, Viscient is driving a revolution in drug discovery, overthrowing the old paradigm of discovery in animal models.
Total Funding:
5725000
Founded Date:
2017-12-01
Industry:
Quantum Chemistry
Employee Number:
11-50
Last Funding Date:
2021-09-15
Funding Status:
private
Headquarters:
San Diego,California,United States,North America
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
5725000
Last Funding Total Usd:
1000000
Last Funding Total Currency:
USD
Last Funding Total Value:
1000000
Founders:
Jeffrey Miner,Keith Murphy
Phone Number:
310-729-9053